Immunome, Inc. (IMNM) Misses Q3 EPS by 24c
Tweet
Share
E-mailGet Alerts IMNM Hot Sheet
Join SI Premium – FREE
Immunome, Inc. (NASDAQ: IMNM) reported Q3 EPS of ($0.78), $0.24 worse than the analyst estimate of ($0.54).
For earnings history and earnings-related data on Immunome, Inc. (IMNM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Utah Medical Products extends share buyback tender offer deadline
- Greenland approves Critical Metals mining plan through 2050
- Bitmine reports 6.02 million ETH holdings, $17.4B total assets
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
